Sovran Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Sovran Advisors's AMGN Position: Q2 2026 in Review
Sovran Advisors reduced its Amgen (AMGN) stake by 38% in Q2 2026, selling an estimated $768K and leaving 3,667 shares worth $1.44M. The position accounts for 0.11% of the portfolio, ranked #210.
Sovran Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.05M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Sovran Advisors held 3,667 shares of Amgen worth $1.44M as of Q2 2026.
- Sovran Advisors sold 2,243 Amgen shares in Q2 2026, an estimated $768K.
- Amgen made up 0.11% of Sovran Advisors's portfolio in Q2 2026, its #210 holding.
- Sovran Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- Sovran Advisors's Amgen position peaked at $2.05M in Q1 2026.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.